Molecular pharming - Open Access .click

Results 171 to 180 of about 1,086 (210)

Polyphenol oxidase silencing avoids protein crosslinking and enzymatic browning in Nicotiana benthamiana leaf extracts

Mahadevan C +4 more
europepmc +1 more source

Plant Molecular Pharming for the Treatment of Chronic and Infectious Diseases [PDF]

Annual Review of Plant Biology, 2014
Plant molecular pharming has emerged as a niche technology for the manufacture of pharmaceutical products indicated for chronic and infectious diseases, particularly for products that do not fit into the current industry-favored model of fermenter-based production campaigns.
Rainer Fischer, Julian K -C, Julian K-C +2 more
exaly +4 more sources

Some of the next articles are maybe not open access.

Related searches:

3. good health
molecular farming
recombinant proteins

humans
biotechnology
plants, genetically modified

2. zero hunger
plants
animals

Transgenic rice endosperm as a bioreactor for molecular pharming

Plant Cell Reports, 2014
Plants provide a promising expression platform for producing recombinant proteins with several advantages in terms of high expression level, lower production cost, scalability, and safety and environment-friendly. Molecular pharming has been recognized as an emerging industry with strategic importance that could play an important role in economic ...
Guo Fengli, Shi Bo
exaly +3 more sources

The emerging role of mass spectrometry-based proteomics in molecular pharming practices

Current Opinion in Chemical Biology, 2022
Molecular pharming relies on the integration of foreign genes into a plant system for production of the desired recombinant protein. The speed, scalability, and lack of contaminating human pathogens highlights plants as an enticing and feasible system to produce diverse protein-based products, including vaccines, antibodies, and enzymes.
Nicholas Prudhomme, Jennifer Geddes-Mcalister +1 more
exaly +3 more sources

Plant ‘molecular pharming’ [PDF]